We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Combined DNA Technologies Analyzed for Malaria Diagnosis

By LabMedica International staff writers
Posted on 08 Nov 2018
Print article
Image: The Loopamp Malaria Pan Detection Kit is a qualitative test for detection of Malaria Pan species (Plasmodium ovale, P. vivax, P. malariae and P. falciparum) in human blood samples (Photo courtesy of Human Diagnostics Worldwide).
Image: The Loopamp Malaria Pan Detection Kit is a qualitative test for detection of Malaria Pan species (Plasmodium ovale, P. vivax, P. malariae and P. falciparum) in human blood samples (Photo courtesy of Human Diagnostics Worldwide).
Malaria is one of the most important parasitic infectious diseases for which almost half of the world’s population is at risk. Although several diagnostic methods are now available to detect the infection, more sensitive and applicable tests are still required in the field.

The loop-mediated isothermal amplification (LAMP) method is a DNA amplification tool in which the DNA amplification can be achieved by incubation at a stable temperature. In parallel, a simple DNA extraction method, the procedure for ultra-rapid extraction (PURE), which can produce a DNA solution suitable for the LAMP reaction without the use of a centrifuge, has also become available.

Scientists at the University of Tsukuba (Ibaraki, Japan) and their colleagues used a nested polymerase chain reaction (PCR) as the reference, and tested 117 samples including 46 Plasmodium falciparum, seven P. vivax, nine P. ovale, four P. malariae, and 51 negative cases. The microscopic diagnosis was conducted by expert microscopists on light microscopes with Giemsa-stained thin blood smears. Rapid diagnostic tests (RDT were conducted using BinaxNow Malaria. DNA was extracted using the Loopamp PURE DNA Extraction Kit and the LAMP reactions were performed with the Loopamp MALARIA Pan/Pf Detection Kit.

The team reported that the PURE–LAMP Pan correctly identified 64 of the 66 positives and the 51 negatives. Among the Pan-positive samples 45 P. falciparum were also detected with the PURE–LAMP Pf. The PURE–LAMP Pan and PURE–LAMP Pf had respective sensitivities of 96.96% and 97.82% and common specificity of 1. All negatives by PURE–LAMP were also negative by microscopy. Only two positive samples by PURE–LAMP [Pan(+)Pf(+)], which were in conformity with the P. falciparum diagnosis by the nested PCR, were misdiagnosed by microscopy as negative.

The authors concluded that filter paper is already a well-known field support method as it allows the collection, transfer, and storage of samples without a cold chamber. Considering the designed-in field-friendliness of this PURE–LAMP combination method, use of this system with dried blood samples will allow maximum exploitation of this characteristic while still performing accurately. The PURE–LAMP system is accurate when used with dried blood spots and extendable to the field. The study was published on October 22, 2018, in the Malaria Journal.

Related Links:
University of Tsukuba

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Respiratory QC Panel
Assayed Respiratory Control Panel

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.